|
|
|
FDA Home Page | Search
FDA Site | FDA A-Z Index | Contact
FDA
Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857
This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.
 |
October 12, 2004 |
|
|||
|---|---|---|---|---|---|
FDA Official and Title |
Date and Site |
Other FDA Participants |
Non-FDA Participants |
Subject |
|
| Daniel E. Troy, Chief Counsel | 9/27/04 Rockville, MD | David Orloff, Kati Johnson, Dragos Roman, CDER; Elizabeth Dickinson, Kim Dettelbach, OCC | Robert Petersen, Michael Bigelow, Jeffrey Fayerman, Dave Ceryaks, Gordon Cutler, Lilly | Humatrope | |
| Daniel E. Troy, Chief Counsel | 9/28/04 Rockville, MD | Elizabeth Dickinson, Kim Dettelbach, OCC; David Orloff,CDER | Scott Bass, Jeff Kushan, Sidley Austin, Brown & Wood; Gene Murano, Heidi Wagner, Roy Hardiman, Kenneth Attie, M.D., Genentech; Mary Pendergast, Pendergast Consulting | Humatrope | |
| Daniel E. Troy, Chief Counsel | 9/28/04 Washington, DC | GPhA Members | IIR/GPhaA 5th Generic Drug Summit presentation | ||
| Daniel E. Troy, Chief Counsel | 10/04/04 Rockville, MD | Bob Myer, Wayne Mitchell, Gene Sullivan, CDER; Lynn Whipkey-Mehley, OCC | Edward J. Allera, Jodi Finder; Harris, Buchanan-Intersoll | Asthma Therapy Coalition: CFCs | |
| Daniel E. Troy, Chief Counsel | 10/05/04 Rockville, MD | Jalena Specht, Beverly Rothstein, OCC | Kathryn Gleason, Morgan Lewis; Stephen Hurley, Hurley, Buraaish & Milliken | Mentor PMA Issues | |
| Daniel A. Casciano, Ph.D.Director, NCTR | 9/20-21/04 Philadelphia, PA | Researchers and scientists from industry, academia and government | 3rd Annual Symposium on Drug-Induced Hepatoxicity | ||
| Daniel A. Casciano, Ph.D.Director, NCTR | 09/27-28/04 NCTR Little Rock, AR | Arkansas Biosciences Institute (ABI Board Members, ABI Science & Industry Advisory Committee Members | Combined meeting of Arkansas Biosciences Institute (ABI) Board & ABI Science & Industry Advisory Committee | ||
| Jesse L. Goodman, M.D. MPH | 9/24/04 Bethesda, MD | CBER Senior managers | Senior management representatives to American Assoc. of Blood Banks (AABB) | FDA Liaison twice yearly to discuss issues in blood regulation of interest to AABB membership | |
| Jesse L. Goodman, M.D. MPH | 9/30/04 Bethesda, MD | Attendees - Cystic Fibrosis Gene Therapy Workshop | Dr. Goodman participated in discussion | ||